Experience Highlights

Counsel, Cantor Colburn LLP, 2020-present

Associate, Cantor Colburn LLP, 2016-2019

Associate, Honigman Miller Schwartz and Cohn LLP, 2014-2016

Associate, Eversheds Sutherland LLP (formerly Sutherland Asbill & Brennan LLP), 2010-2014

Patent Engineer, Osha Liang, 2007

Postdoctoral Fellow, University of Texas – Austin, 2004-2005

Publications

Co-author, “Trademark Clearinghouse and the New gTLDs” (Legal Alert, March 28, 2013).

Co-author, “XXX Domains: Prevention is Better than the Cure” (Legal Alert, September 6, 2011).

Co-author, “ICANN Formally Adopts New Generic Top-Level Domain Name Program, Postpones Application Period” (Legal Alert, June 20, 2011).

Co-author, “New Generic Top-Level Domain Name Application Procedures are in the Home Stretch” (Legal Alert, June 14, 2011).

Co-author, “Unique Active Ingredient in Drug Product Can Mean Patent Term Extension” (Legal Alert, May 17, 2010).

Co-author, “Opinion Letters, Representation Issues, and the Impact of the Seagate and Knorr-Bremse Decisions,” PLI Patent Litigation 2010 Course Handbook #24179 (2010).

Co-author, “Copying Products is Risky Business: Inducing Patent Infringement” (Legal Alert, February 16, 2010).

Author, “Improving the Quality of Healthcare: Resolving Claim Disputes in Medicine,” Alternative Resolutions, Winter 2010, Vol. 19, No. 2, pp. 11-19.

Co-author, “Heme/Non-Heme Diiron (II) Complexes and O₂, CO, and NO Adducts as Reduced and Substrate-Bound Models for the Active Site of Bacterial Nitric Oxide Reductase,” Journal of the American Chemical Society, 127, 3310-3320 (2005).

Co-author, “Efficient photodissociation of O2 from synthetic heme and heme/M (M=Fe, Cu) complexes, “Journal of the American Chemical Society, 126, 16712-16713 (2004).

Co-author, “Photochemical organic oxidations and dechlorinations with a mu-oxo bridged heme/non-heme diiron complex,” Inorganic Chemistry, 43, 8272-8281 (2004).

Co-author, “Synthesis and spectroscopy of micro-oxo (O(2)(-))-bridged heme/non-heme diiron complexes: models for the active site of nitric oxide reductase,” Inorganic Chemistry, 43, 651-662 (2004).

Co-author, “Superoxo, mu-peroxo, and mu-oxo complexes from heme/O2 and heme-Cu/O2 reactivity: copper ligand influences in cytochrome c oxidase models,” Proceedings of the National Academy of Sciences of USA, 100, 3623-3628 (2003).

Co-author, “Synthesis and crystal structures of (fulvalene)W(2)(SH)(2)(CO)(6), (fulvalene)W(2)(mu-S(2))(CO)(6), and (fulvalene)W(2)(mu-S)(CO)(6): low valent tungsten carbonyl sulfide and disulfide complexes stabilized by the bridging fulvalene ligand,” Inorganic Chemistry, 41, 3212-3217 (2002).

Co-author, “Nitric Oxide in Biological Denitrification: Fe/Cu Metalloenzyme and Metal Complex NO_x Redox Chemistry,” Chemical Reviews, 102, 1201-1234 (2002).

Co-author, “Photosubstitution of (fulvalene)tetracarbonyldiruthenium by alkenes and alkynes: First observation of alkyne coupling on fulvalene dimetals and synthesis of a (fulvalene)dimetallacyclopentadiene(alkene) complex,” Organometallics, 21, 749-760 (2002).

Co-author, “Nitric Oxide Reductase from Paracoccus denitrificans contains an oxo-bridged heme/non-heme diiron center,” Journal of the American Chemical Society, 122, 9344-9345 (2000).

Co-author, “Metal Encapsulating Carbon Nanostructures from Oligoalkyne Metal Complexes,” Journal of the American Chemical Society, 121, 10430-10431 (1999).

Co-author, “Penta(cyclopentadienyl)-Ƞ⁵-cyclopentadienylmanganese tricarbonyl: Structure and laser-induced conversion to fullerenes,” Journal of Organometallic Chemistry, 572, 135-139 (1999).